A new therapeutic, DISC-0974, shows significant selectivity for HFE2, the crucial factor involved with mammalian morphogenesis. Early data indicate that inhibiting RGMC/HFE2 signaling with DISC-0974 therapeutic leads https://www.targetmol.com/compound/disc_0974